Literature DB >> 6428739

Drug resistance of hypoxic tumour cells in vitro.

C Ludwig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6428739     DOI： 10.1016/0305-7372(84)90057-4

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  4 in total

1.  Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma.

Authors:  Y Kato; M Yashiro; S Noda; M Tendo; S Kashiwagi; Y Doi; T Nishii; J Matsuoka; Y Fuyuhiro; O Shinto; T Sawada; M Ohira; K Hirakawa
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

2.  Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia.

Authors:  T Bando; K Kasahara; K Shibata; Y Numata; U Heki; H Shirasaki; K Iwasa; M Fujimura; T Matsuda
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1.

Authors:  Chii-Wen Chou; Chi-Chung Wang; Chung-Pu Wu; Yu-Jung Lin; Yu-Chun Lee; Ya-Wen Cheng; Chia-Hung Hsieh
Journal:  Neuro Oncol       Date:  2012-09-03       Impact factor: 12.300

4.  Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions.

Authors:  R S Marshall; M C Paterson; A M Rauth
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.